Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 USD | -3.77% | -3.43% | -78.13% |
May. 22 | Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy | MT |
May. 15 | Virpax Prices Public Offering of Shares, Warrants; Shares Tumble | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 820K |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -15M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.12
x | P/E ratio 2025 * |
-0.31
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.71% |
1 day | -3.77% | ||
1 week | -3.43% | ||
1 month | -72.44% | ||
3 months | -80.06% | ||
6 months | -82.29% | ||
Current year | -78.13% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Gudin
FOU | Founder | 58 | 16-12-31 |
Gerald Bruce
CEO | Chief Executive Officer | 68 | 17-07-31 |
Vinay Shah
DFI | Director of Finance/CFO | 62 | 23-06-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Bruce
CEO | Chief Executive Officer | 68 | 17-07-31 |
Jeffrey Gudin
FOU | Founder | 58 | 16-12-31 |
Director/Board Member | - | 23-03-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.7 | -3.77% | 65,983 |
24-05-30 | 0.7274 | -0.33% | 22,393 |
24-05-29 | 0.7298 | +2.64% | 29,068 |
24-05-28 | 0.711 | -1.92% | 51,598 |
24-05-24 | 0.7249 | +0.68% | 49,567 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-78.13% | 820K | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- VRPX Stock